Bioequivalence Study of Tretinoin Gel 0.05% to Brand Tretinoin Gel

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
This was a double-blind, randomized, three-treatment, parallel study. Normal, healthy male and female children and adults (i.e., ages 12 to 40 years) with at least Grade 2 (i.e., mild severity) acne vulgaris were treated on the full face once daily for 84 days with the Tretinoin Gel 0.05%, Brand (tretinoin) Gel 0.05%, or Gel Vehicle. Acne lesions were graded by a single blinded observer at screening and at Weeks 0 (i.e., baseline), 2, 4, 8, and 12 at each location.
Epistemonikos ID: 5b517a46a38e25a95ea2ede9c4fae16a22bbfd14
First added on: May 12, 2024